secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001641172-25-027210
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics files prospectus supplement for up to $5.83M ATM offering
----------------------------------------------------------------------------

- Company may sell up to $5,830,572 of common stock through H.C. Wainwright as sales agent.
- No shares had been sold under prior ATM agreement as of September 12, 2025.
- Shelf registration statement S-3 (333-284834) declared effective by SEC on September 10, 2025.
- Common stock par value $0.0001 per share; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225027210/0001641172-25-027210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225027210/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-027210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer